2796 — Pharmarise Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- ¥6bn
- ¥15bn
- ¥64bn
- 47
- 76
- 17
- 43
Annual cashflow statement for Pharmarise Holdings, fiscal year end - May 31st, JPY millions except per share, conversion factor applied.
2021 May 31st | 2022 May 31st | 2023 May 31st | 2024 May 31st | 2025 May 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1,202 | 1,322 | 1,049 | 143 | 8 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 130 | 214 | 406 | 731 | 316 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -732 | -2,131 | -161 | 671 | -504 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1,944 | 713 | 2,518 | 2,715 | 1,313 |
| Capital Expenditures | -552 | -466 | -542 | -619 | -702 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -524 | 174 | -161 | -2,501 | -3,760 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,076 | -292 | -703 | -3,120 | -4,462 |
| Financing Cash Flow Items | 95 | -2 | — | -76 | -3 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -728 | -1,034 | -1,072 | 2,771 | 939 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 140 | -613 | 743 | 2,366 | -2,210 |